Newer Targets

Integral Molecular Presents Data on Monoclonal Antibodies (MAbs) Against SLC2A4 (GLUT4), a Critical Target...

Integral Molecular Presents Data on Monoclonal Antibodies (MAbs) Against SLC2A4 (GLUT4), a Critical Target for Diabetes

Treatment targets for men with advanced prostate cancers

Treatment targets for men with advanced prostate cancers

Treatment targets for men with advanced prostate cancers

Treatment targets for men with advanced prostate cancers

Medicago Awarded “Best New Vaccine Technology/Platform” at the World Vaccine Congress

Medicago Awarded "Best New Vaccine Technology/Platform" at the World Vaccine Congress

Cutting-Edge Discovery Points to Potential Treatment for Necrotizing Enterocolitis in Preemies

Cutting-Edge Discovery Points to Potential Treatment for Necrotizing Enterocolitis in Preemies
- Advertisement -

LATEST NEWS

MUST READ